Notify me when Matthew Angel files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| TPST | TEMPEST THERAPEUTICS, INC. | Common Stock, par value $0.001 per share | 36% | $13,205,201 | 4,837,070 | Matthew Angel | 03 Feb 2026 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|